Purpose To assess the feasibility of a one-step surgical concept, employing adipose stem cells (ASCs) and a novel degradable radiolucent cage filler (poly-L-lactide-cocaprolactone; PLCL), within polyetheretherketone cages in a stand-alone caprine spinal fusion model. Methods A double-level fusion study was performed in 36 goats. Four cage filler groups were defined: (i) acellular PLCL, (ii) PLCL ? SVF (freshly harvested stromal vascular fraction highly enriched in ASCs); (iii) PLCL ? ASCs (cultured to homogeneity); and (iv) autologous iliac crest bone graft (ABG). Fusion was assessed after 3 and 6 months by radiography, micro-CT, biomechanics, and biochemical analysis of tissue formed inside the cage after 6 months.
Introduction
To decrease symptoms such as pain and neurological deficit in selected patients, spinal fusion can be considered to decrease excessive motion of the spine and to restore adequate alignment and intervertebral height. To achieve spinal fusion, several techniques have been proposed which can include the use of an interbody spacer (cage). In certain cases, separate grafting of autologous bone is needed both to augment spinal fusion procedures and/or to fill the cage. Autologous bone, having both a scaffolding (osteoconductive) and an osteoinductive function, is still considered the golden standard. However, if needed, harvesting autograft from the iliac crest requires additional surgery at the donor site and is related to a high level of morbidity such as chronic pain, infection, neuromas, vascular injuries, and iliac wing fractures [14, 15] . In addition, in case of insufficient autologous bone available, allograft bone material may be used. However, this also has drawbacks, e.g. living cells (osteoinductivity) are no longer present in bone bank bone, and transmission of diseases may occur.
When cages are filled with either autograft or allograft, the healing area inside the cage on radiographs is obscured, which complicates the monitoring of new bone formation inside the cage, i.e. the progression of the fusion process. The same holds true for calcium phosphate-based synthetic bone substitutes. This specific drawback can be countered using degradable, non-opaque polymers as cage fillers, since their radiolucency allows monitoring of the bone formation process radiographically. Polymers have great design flexibility because their structure, composition and properties can be tailored to specific needs [12] .
In line with tissue engineering concepts, bioactive potential can be introduced by enrichment of these polymers with stem cells. Virtually all tissues contain stem cells and autologous adult mesenchymal stem cells (AMSC) derived from these tissues are often used in tissue engineering to avoid ethical issues and immune responses. The most commonly used source of AMSCs is bone marrow. However, important limitations of bone marrow are the low number of stem cells per volume of bone marrow (about 1 in 100,000 nucleated cells) and the limited amount of bone marrow that can be harvested without peripheral blood dilution. Therefore, in vitro culture expansion is required to obtain sufficient numbers of cells for clinical application. This makes it costly and runs into a number of regulatory restrictions [13] . This has hampered clinical implementation significantly.
A suitable alternative source for AMSCs is adipose tissue, first identified by Zuk and colleagues [22] . The number of AMSCs in adipose tissue is two to three orders of magnitude higher than the number of AMSC in bone marrow [23] . Furthermore, (subcutaneous) adipose tissue can be obtained in substantial quantities and is accessible at most surgical sites, circumventing the need for a separate bone harvest site. Finally, the multilineage differentiation potential of adipose-derived stem cells has been well established [22, 23] . Therefore, adipose-derived stem cells (ASCs), which can be obtained directly after processing adipose tissue as part of a cell-fraction within the so-called stromal vascular fraction (SVF), have clinical potential for the regeneration of tissues [4, 21] , for which Helder and colleagues formulated the theoretical concept of the onestep surgical procedure (OSP) [4] . The proposed concept uses off-the-shelf bioresorbable materials and easily accessible ASCs from adipose tissue, harvested with minimally invasive techniques and in a clinically relevant yield, obviating the need for in vitro expansion. This concept is not only cost effective as compared to cell expansion in vitro, it is also beneficial to the patient, because a second separate surgical intervention is avoided.
The present study aims to examine the feasibility of this theoretical one-step surgical procedure in a well-established lumbar interbody fusion goat model [9, 17, 19, 20] . We used a polyetheretherketone (PEEK) cage filled with a biodegradable 70:30 poly(L-lactide-co-caprolactone) (PLCL) scaffold, seeded with freshly harvested SVF cells. In previous studies, we showed that freshly isolated adiposederived mesenchymal stem cells (generally referred to as stromal vascular fraction or SVF) not only adhered to PLCL in sufficient quantities, but were also able to differentiate along the osteogenic lineage, making PLCL a strong candidate to serve as a radiolucent, degradable scaffold in bone tissue engineering [6, 10] . With the main goal of determining the feasibility of the one-step surgical procedure and to additionally assess the potential of this adipose stem cell seeded cage filler in vivo, we performed a double-level caprine interbody fusion procedure with PEEK cages.
Materials and methods

Animals
Surgical procedure and animal care were performed in compliance with the regulations of the Dutch legislation for animal research and the Animal Ethics Committee of the VU University Medical Center which approved the protocol. In total, 36 skeletally mature female Dutch milk goats (54-103 kg) were used. The goats were killed after 3 months (N = 18) and after 6 months (N = 18) following surgery.
One goat deceased directly following surgery due to cardiac arrest and was replaced (3 months follow-up group).
Cage and cage filler description
Interbody cages were designed equivalent to the cages described earlier [9, 17] . The cages were made of carbon reinforced PEEK with a vertical and rectangular geometry of 10 9 10 9 18 mm, with a wall thickness of 1.5 mm. The cage filler was composed of 70:30 degradable polymer [poly(L-lactide-co-caprolactone)]; PLCL; M w 200 kg/mol, inherent viscosity 1.5 dl/g, glass transition temperature 18-20°C and sterilised using ethylene oxide, and had a porosity of 71 % with axially aligned pores and a pore-size of at least 380 lm (Proxy Biomedical ltd, Galway, Ireland). Tricortical autologous bone, grafted from the left iliac crest, was used as an autologous bone graft.
Experimental cage filler groups and stem cell source Four experimental cage filler groups were defined; autologous bone graft (ABG) and three poly(L-lactide-cocaprolactone) (PLCL) groups, comprising PLCL alone, PLCL seeded with autologous freshly isolated adipose stromal vascular fraction (SVF) cells (see below) and PLCL seeded with previously harvested autologous ASC obtained by culturing SVF cells for at least 2 weeks (for more information on adipose stem cells and its isolation see references [4, 5, 22] and see below).
Freshly isolated stromal vascular fraction cells
SVF cells were isolated as described by Zuk et al [22, 23] , with minor modifications as described earlier [7] . Briefly, digestion was performed using 1 U of Celase Ò (Cytori Therapeutics, Inc, San Diego, USA) per g adipose tissue for 60 min at 37°C After filtration, the adipose stem cell containing cell suspension was resuspended in DMEM without additives (DMEM-) and washed for an additional two times with PBS, before 5 9 10 6 SVF cells in 750 ll DMEM-were directly seeded onto the PLCL cage filler for 30 min in a custom-made seeding device in accordance with the one-step surgical procedure [4] . The non-adherent cells were removed by washing in PBS twice prior to implantation.
Adipose stem cells
Fresh adipose SVF cells were harvested during a separate surgery, 2 weeks prior to the spinal fusion surgery. These cells were resuspended in culture medium and seeded either in a 75 cm 2 culture flasks (Greiner Bio-One, Kremsmuenster, Austria) or in a 6-well plate to determine the colony forming unit assay, which indicates the amount of stem cells present in SVF using the ability to form a colony. Upon 80 % confluency, adipose stem cells were harvested, and cultured up to passage 2-3. Cultured cells were seeded onto the PLCL cage filler during spinal fusion surgery according to the explicit ratio of stem cells present in the corresponding 5 9 10 6 SVF for each animal and allowed to attach in DMEM-for 30 min. The non-adherent cells were removed by washing in PBS twice prior to implantation.
To assess the role of additional cell types within heterogeneous SVF group (e.g. endothelial cells, smooth muscle cells, leucocytes), the SVF group was compared to the ASC group, which was obtained by prolonged culturing SVF to a homologous stem cells colony (ASC).
Surgical technique
Surgery was performed under general anaesthesia with endotracheal intubation. Prophylactic antibiotic treatment (200 mg procaïnebenzylpenicilline, 250 mg dihydrostretomycinesulfaat per ml per 25 kg body weight, i.m.) was administered once before surgery. Prior to and following the spinal fusion procedure, standard lateral radiographs were taken to verify the number of lumbar vertebrae (5-7) and the presence of spontaneous disc degeneration.
Obtaining adipose tissue
Through a left paravertebral approach approximately 100 grams of perirenal adipose tissue was manually harvested and directly processed in a tissue engineering lab. The adipose tissue for the ASC group was obtained similarly, but acquired 2 weeks prior to spinal fusion surgery and using a right paravertebral approach.
Obtaining iliac crest bone
A skin incision was made over the left iliac crest. After freeing the iliac crest of overlying tissue, a 20 mm deep rectangular defect was made using a custom-made box gauge (10 9 10 mm). The obtained tricortical bone was minced and used to impact the cage.
Spinal fusion procedure
This procedure has been described in detail elsewhere [9, 17, 18] . Briefly, L1-L2 and L3-L4 were identified via a left retroperitoneal approach using fluoroscopy. The intervertebral discs (IVD) of interest were exposed after mobilization of the psoas musculature. Under fluoroscopic guidance, a 2-mm guidewire was centred transversely in the IVD. An 8-mm drill bit was placed over the guidewire through the IVD and the adjacent endplates. The 10 9 10 mm box gauge was placed over the drill and used to punch a transverse rectangular defect, after which a cage, containing one of the four experimental fillers, was inserted. Directly after surgery, a standard lateral radiograph was taken from the lumbar spine (Fig. 1) . The caprine lumbar intervertebral discs are about half the size of a human disc [8, 16] , resulting in a disc height of 4-5 mm [16] . Using a 10 9 10 mm box gauge both endplates are removed and trabecular bone can be seen during surgery. With a trabecular bone density about twice that in humans, it can withstand axial compression with the endplates opened [16] , in contrast to the human situation, in which the endplates are therefore carefully prepared.
Following wound closure, the animals returned to their cages and receiving 0.6 mg buprenorvine i.m. as an analgesic. After 1 week, when wound healing was completed, the animals were moved to a large indoor and outdoor environment without restrictions. Health status, eating habits and ambulatory activities were monitored daily. At the designated time, the goats were sedated with 10 mg/kg ketamine intramuscularly, and lateral radiographs were taken. Thereafter, the goats were euthanized with an intravenous overdose of sodium pentobarbital (20 mg/kg), after which gross pathological examination of the thorax, abdomen and organs was performed and subsequently, the lumbar spines were harvested, trimmed of residual musculature and radiographed in two directions (lateral view and anterior-posterior view).
Biomechanical testing
For biomechanical testing after 3 and 6 months follow-up, at least four segments for every cage filler group were analysed. Specimen preparation was performed as described earlier [11] . Briefly, immediately after killing, the lumbar spines were excised at the Th12-Th13 level and at the L5-L6 level, resulting in a single specimen from Th13 up to L5. Subsequently, the spines were trimmed of residual musculature, while leaving all ligamentous tissue intact, wrapped in PBS soaked towels and stored at 4°C. Within 24 h, the spines were prepared by rigidly fixed L-shaped markers in the ventral-midsagittal plane on each vertebral body (N = 4), each marker containing three lightemitting diodes (LEDs) for optoelectronic 3D movement registration. The cranial (Th13) and the caudal (L5) spine ends were completely embedded in two metal cups, filled with cerro-low 147 (Cerro Metal Products Co., Bellefonte, PA) heated at 60°C. The intervertebral discs of Th13-L1 and L4-L5 were not embedded and there by allowed full movement of the three motion segments. During the preparation and testing procedure, the specimens were kept moist by spraying with saline solution (NaCl 0.9 %).
Biomechanical testing was performed as described earlier [3] using a custom-made four-point bending device in which flexion/extension, right and left lateral bending and right and left axial rotation could be applied. The testing device was driven by a Zwick mechanical material testing system (Zwick Roell, Ulm, Germany), mounted on a hydraulic mechanical testing device (Instron 8872, Canton MA, USA). The lumbar spine was positioned in its neutral, horizontal position where the load was set to 0. Subsequently, moments of 3 Nm were gradually applied in the tested direction, with a rotation speed of 1 degree/second. For axial rotation, the maximum applied moment was 2 Nm. Specimens were tested for ten continuous cycles and the average data of all cycles were analysed. Motions of the LED's were recorded by an optoelectronic 3D movement registration system with an array of 3 cameras (Optotrak 3020, Northern Digital Inc, Waterloo ON). Before testing, the axes of the Optotrak system were aligned with the anatomic axes of the spinal segment.
A customized programme written in Matlab (Mathworks, Natick MA, USA) was used for data analysis. Movement in the main intended direction (flexion/extension, lateral bending and axial rotation), was plotted as a function of load to obtain moment-angular displacement curves.
The range of motion (ROM) of each motion segment was calculated from the load-displacement data. The range of motion was calculated as the maximum angular motion between the maximum moments in positive and negative directions.
Micro computed tomography (micro-CT)
The lumbar spines were dissected at the operated motion segments, resulting in one single motion segment of either L1-L2 or L3-L4. For both 3 and 6 months follow-up, all four cage filler groups had four segments analysed. Micro-CT scans were obtained at a resolution of 36 lm (Micro-CT80, Scanco Medical, Brüttisellen, CH). Image processing included modest Gaussian filtering (sigma = 1, support = 2 voxels) after which the images were thresholded to segment the mineralized phase. The threshold was set to 160 per mille, corresponding to 295 mgHa/cm 3 . From the segmented images, several calculations were made. Firstly, the bone volume as a fraction of the total cage volume (BV/TV), secondly the average trabecular thickness and lastly, the trabecular number/mm were calculated. To avoid overestimation of the mineralized tissue within the PLCL scaffold, two segments from the replaced goat (deceased directly following surgery) were scanned and as expected no mineralized tissue was measured using this threshold. A total of 16 segments in both the 3 months group and 6 months group were analysed.
Radiographic score
After biomechanical testing or micro CT scanning, the operated motion segments were excised and paramidsagittal Sections (4 mm) were made using a water-cooled band saw (EXAKT, Norderstedt, Germany) and digitally photographed. Lateral radiographs of these sectioned specimens were used to estimate interbody fusion, based on a validated radiographic score (RS) [11] . For the radiographic score, the rectangular cage on the radiograph was divided in three equal parts along the spinal axis (Fig. 2) . When no bone ingrowth was observed, a radiographic score of 0 was given to the segment. For RS 1, bone ingrowth was present in the outer one-third of the cage, and when bone had grown into the middle third, a radiographic score of 2 was set. RS 3 was achieved when bony contact was present in the sagittal plane of the cage, while the presence of a ventral bony bridge (sentinel sign) was also given a RS 4 score, independent of the RS score within the cage (Fig. 2) .
Biochemical analysis
As an indicator for the quality/maturation of the collagen formed in the cages, the collagen content and the numbers of the two enzymatic mature cross-links hydroxyllysyl pyridinoline (HP) and lysyl pyridinoline (LP) per triple helix were assayed as described in detail elsewhere [1] . The material was obtained using a midsagittal section of the cage. Briefly, the bone samples were freeze dried and weighed. Samples were hydrolyzed with 6 M HCl at 110°C for 20 h. After drying samples were dissolved in 100 ll of internal standard solution (10 nmol pyridoxine/ ml water and 2.4 mmol homoarginine/ml water). The amount of hydroxyproline (Hyp), proline (Pro) and the collagen LP/HP cross-links in these samples were determined by reversed-phase high-performance liquid chromatography (HPLC). To calculate the amount of collagen cross-links per triple helix the amount of HP ? LP (pmol) in the sample was divided by the total amount of collagen (=Hyp/300). Values were expressed as total amount of residues per collagen molecule, assuming 300 Hyp residues per triple helix.
As a control, a PLCL scaffold was hydrolysed and processed as described above to confirm that PLCL did not interfere with the HPLC analysis.
Statistical analysis
Statistical analysis was performed using Instat statistical analysis software (Graphpad Software Inc., San Diego, USA). All data were tested for normal distribution using the Kolmogorov-Smirnov (KS) test and depending on the data, appropriate parametric or non-parametric tests were used.
Range of motion between the experimental groups was analysed using a Kruskal-Wallis analysis followed by Dunn's multiple comparison test. Comparison within each group between the 3 and 6 months time-points was done using a Mann-Whitney test.
The bone volume as a ratio of total volume (BV/TV) between the groups was analysed using a Kruskal-Wallis with Dunn's multiple comparison test.
A Mann-Whitney test was used to analyse the differences between 3 and 6 months within each experimental cage filler group. 2 Accompanied by actual radiographs, a schematic lateral diagram in which the rectangular interbody spacer is divided into three equal parts to obtain a radiographic score (RS) ranging from 0 (no bone ingrowth) to 4 (ventral bony fusion) is depicted. The presence of bone in each or both of the outer thirds of the cage, resulted in a RS 1 (1) . Bone present in the middle third of the cage but without bridging contact was indicated RS 2 (2), and RS 3 was scored when a bony fusion inside the cage was present (3) . With the presence of a ventral bony fusion, the RS score of 4 was indicated irrespective of the bone formation inside the interbody spacer (4) The inter-observer agreement for the RS score was calculated using Cohen's kappa value and the differences in the presence of fusion (RS 3) were analysed using binary logistic regression. The biochemical analysis was compared using a Kruskal-Wallis test. Differences were considered statistically significant when p \ 0.05. The differences in fusion or no fusion were detected using a binary logistic regression analysis.
Results
All experimental goats included in this study recovered uneventfully from the surgical procedure and no complications were observed during the follow-up period. Normal ambulatory activities were regained on the second-postoperative day.
At killing, excised spines underwent either micro-CT scanning (n = 4 for all groups at 3 and 6 months) or biomechanical testing (n = 4 for all groups at 3 and 6 months, except SVF and ABG n = 5 at 6 months). The standard lateral radiographs showed lumbosacral transitional anomalies in five goats, with lumbarisation (L7) in four goats and sacralisation (L5) in one goat. No spontaneous disc degeneration was observed. After performing either biomechanical testing or micro computed tomography, paramidsagittal slices of the cage were obtained. The digital photographs from these slices revealed no sign of osteolysis and/or infection. The PLCL scaffold material was however, still present inside the cage up to 6 months and therefore at most only partly degraded.
Radiographic score
Pre-killing lateral radiographs and those of excised lumbar spines could not be used to determine the radiographic score due to overlapping soft tissue contours and/or transverse processes in some cases. Therefore, in accordance with van Dijk et al. [18] , the lateral radiographs of the paramidsagittal sections were scored by two observers (RJK and MH). The kappa value concerning the interobserver reliability of this modified RS score was 0.82. In the event of a different score, both observers discussed the radiograph and assigned the appropriate score to the corresponding segment. From 72 scored segments, 2 segments (ASC en ABG, both in the 6 months follow-up group) could not be included due to irretrievable data loss.
An overview of the radiographic scores for all experimental groups in all time-points is given in Table 1 . Interbody fusion (RS 3) after 3 months was achieved in 1/9 for the PLCL group, 0/9 for the SVF group, and 2/9 for the ASC group, while 5/9 segments were fused in the ABG group. No significant differences could be detected between the four groups (p = 0.25). When combining the number of sentinel signs (RS 4) and number interbody fusions (RS 3) to obtain a total fusion rate, the PLCL group contained 1/9 (11 %) fusions; the SVF group had no fusion 0/9 (0 %); the ASC group fused 3/9 (33 %) segments; and 5/9 (56 %) fusions were observed in the ABG group. Interbody fusion rates increased after 6 months to 3/9 in the PLCL group, 3/10 in the SVF group, 3/7 in the ASC group and 5/8 in the ABG group. Again no significant differences could be detected (p = 0.54). At 6 months post surgery, total fusion rates (RS3 ? RS 4) were observed in 5/9 (56 %) cases in the PLCL group, 7/10 (70 %) cases in the SVF group, 5/7 (71 %) in the ASC group and in the ABG group 6/8 (75 %) (no significant differences).
Since we have found great differences with respect to the stage of spinal fusion within each cage filler group, we have depicted the best and the worst case from each group after 3 and 6 months (Fig. 3A, B) . In the ABG group, the best cases showed a solid bony bridge. For the PLCL based groups, even in the best cases, the bony bridge was less solid, due to the presence of scaffold material inside the cage. Although not quantified, the bony bridge in the SVF group at 6 months seems to be more solid compared to the PLCL and ASC groups. Biomechanical testing
Flexion-extension
Analysis of the motion segments for the range of motion (ROM in degrees) in flexion-extension present 3 months after spinal fusion surgery resulted in similar range of motions between the groups (p = 0.58) ( Table 2 ; Fig. 4A ). After 6 months, in the ABG group one segment was excluded from the flexion/extension analysis, due to insufficient fixation of an optoelectronic marker. Statistical analysis showed a significant smaller range of motion for ABG compared to PLCL (p \ 0.05) ( Table 2 ; Fig. 4A ). Finally, no statistical differences were found when comparing each cage filler over time, i.e. between 3 and 6 months follow-up (Fig. 4A) .
Lateral bending
The measured range of motion for lateral bending after both 3 and 6 months resulted in the subsequent similar values of range of motions between the cage fillers (p = 0.77 and p = 0.45, respectively) ( Table 2 ; Fig. 4B ).
Comparing the different time-points for each cage filler indicated a significant decrease in range of motion for the PLCL group after 6 months compared to the 3 months PLCL group (p \ 0.05) (Fig. 4B) .
Axial rotation
The third direction measured, axial rotation, gave nonsignificant different ranges of motion (p = 0.77) 3 months after surgery (Table 2 ; Fig. 4C) .
Range of motion 6 months post surgery revealed similar findings between the four cage filler groups. These values were not significantly different (p = 0.31) A significant difference (p \ 0.05) between both PLCL groups (3 and 6 months) was found when comparing the two different time-points (Fig. 4C) .
Micro computed tomography (CT)
An overview of the data is given in Table 3 and Fig. 5 . The amount of mineralized tissue inside the cage [bone volume PLCL (4) (BV)] is expressed as a fraction of the total volume (TV) within the cage (BV/TV). Three months after spinal fusion surgery, PLCL contained 7.3 % mineralized whereas SVF contained 3.4 % mineralized tissue. The addition of cultured stem cells to the PLCL resulted in 7.5 % mineralized for the ASC group, while the control group (ABG) contained 50.2 % mineralized tissue. Statistical analysis showed a significant higher amount of mineralized tissue for the ABG group compared to the SVF group after three months (p \ 0.05) ( Table 3 ; Fig. 5A ).
With respect to the number of trabecules per mm, no differences were detected between the groups after 3 months (p = 0.055) ( Table 3 ; Fig. 5B ).
Trabecular thickness (cm) differed significantly only between the ABG and ASC group after 3 months (p \ 0.05) ( Table 3 ; Fig. 5C ).
Six months after surgery, no significant differences in the amount of mineralized tissue between the cage fillers were detected (p = 0.125) (Fig. 5C ). Comparing the timepoints of each cage filler, the amount of mineralized tissue in the PLCL group was not significantly (p = 0.11) increased to 15 %. A similar non-significant increase (p = 0.06) was seen in the SVF group with 13.8 % mineralized tissue. The ASC group contained 15.2 % mineralized tissue, again not significantly higher compared to the 3 months ASC group (p = 0.11). Mineralized tissue in the ABG group comprised 44.8 % of the total volume of the cage, similarly to the 3 months ABG group (p = 0.99) ( Table 3 ; Fig. 5A ).
Trabecular number per mm, was significantly higher in the ABG group compared to the PLCL group (p \ 0.05) (Fig. 5B) .
Trabecular thickness (cm) was comparable between all groups (p = 0.26) ( Table 3 ; Fig. 5C ).
Biochemical analysis
Biochemical analysis of the quality/maturity of the collagen formed after 6 months was analysed by means of measuring the matured cross-links of the collagen. The material was obtained using a midsagittal section inside the cage. No statistical differences in the HP ? LP per triple 
Discussion
As an alternative to morbidity-associated autologous bone grafting (ABG), a novel bone tissue engineering concept was evaluated for feasibility, safety and efficacy. We used a one-step surgical procedure (OSP), in which stem cells are isolated from subcutaneous adipose tissue, seeded on a polymeric scaffold, and re-implanted within the same surgery. We filled the cage with a radiolucent poly(L-lactide-co-caprolactone) (PLCL) scaffold material to allow real-time monitoring of in vivo bone formation using plain radiography. By applying this theoretical concept in our goat spinal fusion model [9, 17, 19, 20] , we confirmed the feasibility of this OSP for (pre-) clinical tissue engineering purposes. The pre-estimated 3 h time-frame was indeed realistic, when adequate facilities such as an tissue engineering laboratory are in close proximity to the surgical theatre. The benefit of using radiolucent PLCL as a scaffold was clear from the fact that in the PLCL groups, but not in the ABG group, the progress of interbody fusion could be visualized using plain radiography. In the followup periods of 3 and 6 months, no local and/or systemic adverse effects of PLCL such as osteolysis were observed during autopsy and macroscopic inspection. Furthermore, the addition of freshly isolated (SVF) or cultured adipose stem cells (ASCs) did not lead to any adverse effects. These findings are in corroboration with data from a previous pilot study [20] , in which no severe histological foreign body reaction was observed, thus ensuring the safety of the concept. Although this study resulted in a proof of concept for the OSP and the radiolucent cage filler, autologous bone grafting is still a superior cage filler material. Furthermore, no added value of the employed stem cells was observed in this study. Interbody fusion was defined as the occurrence of a bony bridge through the cage (RS3). When comparing the groups after 6 months, the PLCL based groups had a trend towards a lower fusion rate (30-43 %) compared to the ABG group (63 %), thereby demonstrating the superiority of the latter over PLCL based groups. Interestingly, when we incorporated the presence of an anterior bony bridge (sentinel sign; RS4) into the analysis, as also common in current clinical practise, the total number of vertebral fusions for the PLCL group increased to 56 %, while both the SVF (70 %) and the ASC (71 %) group reached values comparable to the ABG group (75 %). Although, the sentinel sign is considered the most stable and often clearly visible on plain radiography type of fusion, in this study we could not explain the relatively higher presence of sentinel signs in the cell-based PLCL groups and could not attribute this phenomenon to the added cells inside the confined cage.
For all parameters studied (biomechanical testing, micro CT analysis and radiographic score), virtually no significant differences were observed between the cell-based groups and the PLCL group at all time-points. This was unexpected, since our previous study indicated higher osteogenic potential for the SVF group, as we found more mature blood vessels in the SVF vs. the PLCL group after 30 days follow-up [20] . We therefore hypothesized that enhanced angiogenesis would concomitantly accelerate osteogenesis. Also, we did not find differences between freshly isolated SVF, consisting of a heterogeneous mixture of cell types including the ASCs, and ASCs devoid of other cell types by culturing them to homogeneity with respect to both the number as well as the rate of interbody fusions. The limited contribution of the other cell types than the adipose stem cells within SVF may be due to the rapid seeding protocol. We have previously shown that mainly the stem cells within the SVF adhere to PLCL [6] , and therefore the majority of the other cell types are washed out of the scaffold, prior to implantation.
Despite the increased instability created after surgery, we have obtained respectable fusion rates in the past as demonstrated by van Dijk et al. [17] . However, this previous study utilised bone impaction grafting of the degradable cage in all groups. This could well have attributed to the overall mechanical stability of the cage/cage filler construct, thereby diminishing the overall post-surgical instability. Moreover, an earlier caprine spinal fusion study performed by Krijnen et al. [9] , found an increase in spinal fusion rate when unilateral anterior instrumentation was used compared to stand-alone cages. Since van Dijk et al., used a different type of degradable cage (i.e. slower degradation rate and mechanically more stable) compared to Krijnen et al., the importance of mechanical stabilisation during the spinal fusion process was established. In this study, we have used non-degradable and mechanically sufficient cages. Nevertheless, our PLCL cage filler is rather mouldable at body temperature, and will likely not contribute to load bearing, in contrast to the ABG as argued above. This difference might be a possible explanation for the differences found with respect to spinal fusion rates between the PLCL groups and the ABG group. Although we did not observe any differences between the groups after 3 months in the biomechanical analyses, the early post-surgical mechanical situation might be of pivotal importance. This corroborates with the observed post-surgical increase in segmental instability after unilateral stand-alone cage insertion ex vivo [11] . Lack of stability may well explain the relative high number of anterior bone bridges (sentinel signs) in our study. In fact, this sentinel sign has been described as a possible consequence of progressive instability and has therefore been termed 'radial bone spur' instead of interbody fusion [2] . Mineralized bone content as measured with micro CT, was lower for all PLCL groups compared to autologous bone as a filler material, but all show an increase from 3 to 6 months as may be expected. For the ABG group the rather high value of 50.2 % BV/TV after 3 months, is likely due to the presence of the inserted grafted bone. From the micro CT data it can be concluded that the addition of either freshly isolated or cultured adipose stem cells does not lead to an accelerated spinal fusion rate in this study.
The biochemical quality of the bone however, as measured by biochemical analysis, was determined to be similar with respect to the level of mature collagen cross-links, and sufficient to ensure similar biomechanical characteristics between all groups. Therefore, it can be stated that although total mineral content is lagging compared to autologous bone, the quality and concomitant biomechanical characteristics of the PLCL groups appear identical in achieving mechanical stability compared to ABG.
The degradation rate of the PLCL cage filler was lower than anticipated, which may have hampered bone formation, by occupying volume for the newly bone to be formed. In this respect the scaffold properties should be tuned with respect to a more rapid degradation rate for future experiments. Further hampering of bone ingrowth into the cage could be due to a previously reported finding on the PLCL scaffolds: the mean porosity significantly decreased from 71 to 57 % (±4.50 %) (p \ 0.01) after 30 days follow-up [20] and was suggested to be the result of swelling of the material. This corroborates with the observation of minor bulging of the scaffold outside the cage in some paramidsagittal sections (details not shown).
Although direct contact to the vertebral bone generally promotes osteoconductivity, compression of the struts of the PLCL scaffold at the bone-scaffold interface may on the other hand have reduced the accessible area for bone conduction. The swelling issue was unexpected, and initial porosity values should likely be increased to compensate for the observed swelling phenomenon.
Finally, the dimensions of the cages used exceeded the diameter of the vertebral bodies in some cases. In these cases, the cage protruded laterally from the vertebral bodies and therefore the PLCL cage filler was not fully enclosed by bone. We have previously observed rapid fibroblast ingrowth into the PLCL material and thereby hampering bone formation/ingrowth (data not shown) when not fully enclosed by bone. A smaller cage dimension might therefore lead to better and more comparable results.
In conclusion, this study indicates that the concept of the one-step surgical procedure using adipose stem cell (ASC) preparations is a feasible, and potentially safe procedure for bone tissue engineering purposes. Our findings that the radiolucent polymeric (PLCL) scaffold allowed clear observation of bone bridging using plain radiography without evoking adverse effects such as foreign body reactions, may indicate its potential for clinical applications.
Since large variations were observed within each cage filler group with respect to the amount of bone ingrowth into the cage (Fig. 3) , further studies to optimize the surgical technique, cell dosages, scaffold properties (porosity, degradation rate) and cage dimensions are warranted. When these optimizations are in place, it will allow us to draw more sound conclusions on the suitability of PLCL as a cage filler material and on the possible added value of stem cell supplementation in spinal fusion applications, and their role in the replacement of autologous bone and its associated donor site morbidity with intra-operatively stem cell-bioactivated bone substitutes.
